MedTrace Logo

Long-term Clinical Effectiveness of the Delta Xtend Reverse Total Shoulder

NCT00737087 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2016-04-21

No results posted yet for this study

Summary

This post-marketing study is designed to collect data relating to the use of the Delta Xtend™ Total Shoulder Replacement System in shoulder with rotator cuff deficiencies. This allows for continued monitoring of the performance and safety of the prosthesis in a broader range of clinical situations.

Conditions

  • Cuff Tear Arthropathy
  • Osteoarthritis With Cuff Deficiency
  • Rheumatoid Arthritis
  • Post Traumatic Injury to Shoulder
  • Revision Surgery of a Failed Anatomic Shoulder Prosthesis

Interventions

DEVICE

Delta Xtend Reverse Total Shoulder

Orthopaedic implant for total shoulder replacement

Sponsors & Collaborators

  • DePuy International

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2013-10-31
Completion
2015-08-31

Countries

  • Belgium
  • France
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00737087 on ClinicalTrials.gov